ATOS

Conviction 17HealthcareScan · Mon, Aug 10, 2026

Bullish engulfing

ATOS$2.38+0.85%

ResistanceSupportVol 14

Vol MA14 46.2K

May 11May 28Jun 16Jul 6Jul 23Aug 10

ATOSSA THERAPEUTICS, INC.PHARMACEUTICAL PREPARATIONSwww.atossatherapeutics.com ↗

Price2.38

Change+0.85%

Gap-1.06%

Rel volume1.23×

Avg volume62.1K

Avg $ vol146.05K

SMA 202.35

SMA 502.69

SMA 2002.98

Price vs 50-11.66%

Price vs 200-20.18%

MA stackbearish

50/200 crossdeath · 4d

Supertrenddown · 2.57

RSI (14)48

MACD hist0.05

MACD cross—

Stoch %K / %D66 / 63

ADX (14)19

+DI / −DI18 / 21

RSI divergence—

MACD divergence—

ATR %+7.42%

ADR %6.67%

52w high6.17

52w low0.5650

From 52w high-61.43%

Above 52w low+321.24%

New 52w highNo

SqueezeOn · 9d

Bollinger width18.02%

%B0.57

Donchian pos60.00%

Donchian high2.60

Donchian low2.05

AVWAP (52w high)3.67

vs AVWAP high-35.20%

AVWAP (52w low)3.23

vs AVWAP low-26.24%

OBV trendFlat

Chaikin MF (20)-0.08

Today vs 20d1.23×

Avg vol (14d)46.2K

Avg vol (20d)62.1K

Avg $ vol (20d)146.05K

Market cap—

RS 3m (vs SPY)-64.07%

RS 6m (vs SPY)-69.84%

RS line new highNo

Trend template3/8

Technical rank14.8

1 week+9.68%

1 month+0.42%

3 months-57.50%

6 months-55.43%

1 year+208.17%

YTD+277.42%

P/E-0.69

P/B0.89

P/S—

P/FCF-0.80

EPS-4.04

Div yield—

ROE-129.59%

ROA-107.71%

Debt/Eq—

Current5.69

EV/EBITDA0.06

Gross margin—

Net margin—

Rev growth0.00%

EPS growth-36.33%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-2.24M

Revenue0

Net income-8.49M

Gross profit0

Free cash flow-29.79M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out—

Employees14

ListedThu, Nov 8, 2012

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction17 / 100

Pattern quality—

Tech rank14.8 / 100

Group rank86 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish engulfing

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ATOS

All disclosures →

No recent disclosed trades by Congress in ATOS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ATOS · 6 buys

Insider	Side	Shares	Value	Traded	Filed
Chen Shu-Chih Director · Common Stock · 2026-05-12	Grant	10K	$0	2026-05-12	2026-05-14
Steinhart Richard I Director · Common Stock · 2026-05-12	Grant	10K	$0	2026-05-12	2026-05-14
Chen Shu-Chih Director · Common Stock · 2026-05-12	Other	—	—	2026-05-12	2026-05-14
Remmel H. Lawrence Director · Common Stock · 2026-05-12	Grant	10K	$0	2026-05-12	2026-05-14
Galli Stephen J Director · Common Stock · 2026-05-12	Grant	10K	$0	2026-05-12	2026-05-14
Finn Jonathan Director · Common Stock · 2026-05-12	Grant	10K	$0	2026-05-12	2026-05-14
Cigler Tessa Director · Common Stock · 2026-05-12	Grant	10K	$0	2026-05-12	2026-05-14

SEC filings

EDGAR filings in ATOS · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.